PHARMA BULLETIN ⚕️

1.Indian Medical Association writes to PM Narendra Modi on Ramdev statement.
The Indian Medical Association appeal to PM Narendra Modi to take strict action against Ramdev over his statement questioning the efficacy of Allopathy drugs and Doctors.
2.Zydus Cadilla and TLC Ink Pact to market Liposomal Amphotericin B.
Zydus Cadilla and Taiwan based Pharma firm TLC have signed an agreement to market Liposomal Amphotericin B, a drug for treatment of Mucormycosis.
3.VAV Life Sciences to increase lipid production for black fungus drug.
VAV Life Sciences is ramping up production of crucial lipid ingredients used in making Liposomal Amphotericin B.
4.Our Covid Vaccine highly effective Pfizer to Govt.
Pfizer has told Indian Govt.that vaccine has shown high effectiveness against SARS-COV-2 varriant prevalent in India. While suitable for everyone age 12 yrs or above and stored for month 2-8 degree Celsius temperature.
5.20 Crore dose given, 34% above 45 have got Ist Jab.
With more than 20 Crore dose of Covid Vaccine administration 34% above 45 and 42% above 60 population received first vaccine dose, Health Ministry said.

Comments

Post a Comment

Popular posts from this blog

PHARMA BULLETIN ⚕️

Image
PHARMA UPDATES ⚕️ 1.Zydus vaccine for children above 12 years could be available by August. National technical advisory board group of Immunisation ( NTAGI ) chairman Dr Arora also added that the trials are likely to be Completed by the end of next month. 2.India achieve milestone of conducting 40 crores Covid sample testing. India has tested 40,18,11,892 samples across the nation till 25 June 2021 The Indian council of Medical Research said. 251 doctors Challenge Govt. FIR Diktat. -Ahmedabad: A group of 251 graduate students and super-specialists practicing in Gujarat approach the Gujarat High Court to challenge the decision of the state government to join Covid-19’s obligations and call for obligations. I submitted a FIR as not responding. 4. Serum institute of India produce more than 10 crore Doses of covishield in June. The Drugs Controller General of India (DCGI) on Sunday said that the Serum Institute of India has produced 10 crore
Read more

PHARMA BULLETIN ⚕️

Image
PHARMA UPDATES ⚕️ 1. Covid 19 Vaccine effective for at least 1 year :- Karnataka Virologist. Karnataka based Virologist Dr V Ravi said that available evidence suggests that vaccinated person would get protection for two to three years If more troubling Variants don't emerge. 2.Indian Immunologicals to begin Drug substance production for Covaxin from June. Indian Immunological Limited has announced it's plan to start the production of drug substance for Covaxin From June and Despatch the first Batch to Bharat Biotech by July. 3. Zydus Cadilla plans test for its Covid Vaccine in 5 to 12 years age group. Zydus Cadilla is planning to start Clinical trials of its Covid Vaccine, ZycoV-D, in children of 5 to 12 years age group. 4. Modern laboratories to mfg. Amphotericin B. Amphotericin B is Used for treatment of Black Fungus, White Fungus and Yellow Fungus. 5.IIT Hyderabad researchers develop oral an solution to treat black
Read more

PHARMA BULLETIN⚕️

Image
PHARMA UPDATES ⚕️ 1.BDR Pharma launches drug to treat advances tage Ovarian and Prostate Cancer. BDR Pharma has launched Rucaparib under brand name BDPARIB. It first affordable drug treat Ovarian and Prostate Cancer. 2.Seeking Pills to cure Covid Pharma Companies eye alternative to vaccine. Many drug makers are working on so called oral antivirals which would copy what drug Tamiflu does for Influenza. 3.Lupin gets $50 Million from Boehringer for anticancer drug. Lupin has received payment of around Rs.363.5 Crore from Boehringer Ingelheim for achievement of key milestones by its cancer drug potential drug therapy for cancer patients. 4.Agrrement signed b/w Bharat Biotech Gujarat Covid Vaccine Consortium. Memorandum of understanding (MoU) has signed b/w Bharat Biotech and Gujarat Covid Vaccine Consortium for contract Mfg.drug substance for Covaxin. 5.Zydus Cadilla has sought drugs Controller General of India (DCGI)  Approval to
Read more